Several analysts have recently updated their ratings and price targets for Clorox Company (The) (NYSE: CLX):

  • 8/9/2017 – Clorox Company (The) had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $137.00 price target on the stock, up previously from $136.00.
  • 8/4/2017 – Clorox Company (The) had its “equal weight” rating reaffirmed by analysts at Barclays PLC. They now have a $136.00 price target on the stock, down previously from $140.00.
  • 8/3/2017 – Clorox Company (The) was given a new $150.00 price target on by analysts at BMO Capital Markets. They now have a “buy” rating on the stock.
  • 8/2/2017 – Clorox Company (The) had its “hold” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $115.00 price target on the stock.
  • 7/31/2017 – Clorox Company (The) was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Clorox's solid brand portfolio places it well to sustain in the currently challenging environment. Further, the company remains keen on the execution of its 2020 Strategy, which is aimed at boosting growth and overall market share. However, the company has underperformed the industry in the last three months. The company’s significant global presence exposes Clorox to foreign currency risks, which have been hurting its results for a while now. Also, these woes and higher commodity and trade promotion costs are expected to hurt Clorox’s gross margin in fiscal 2017. Nonetheless, the trade investments are aimed at supporting product innovation, which should help Clorox counter stiff competition. In fact, management expects these investments to fuel sales and volumes in the fourth quarter, where EBIT is also expected to rise. All said, Clorox is on track for another strong year, despite slowing economies and a tough consumer landscape.”
  • 7/31/2017 – Clorox Company (The) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating.
  • 7/24/2017 – Clorox Company (The) was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating.
  • 7/22/2017 – Clorox Company (The) had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $137.00 price target on the stock, up previously from $126.00.
  • 7/5/2017 – Clorox Company (The) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/4/2017 – Clorox Company (The) was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $149.00 price target on the stock. According to Zacks, “Clorox has outperformed the broader sector on a year-to-date basis. The company’s solid brand portfolio places it well to sustain in the currently challenging environment. Further, the company remains keen on the execution of its 2020 Strategy, which is aimed at boosting growth and overall market share. However, significant global presence exposes Clorox to foreign currency risks, which have been hurting its results for a while now. Also, these woes and higher commodity and trade promotion costs are expected to hurt Clorox’s gross margin in fiscal 2017. Nonetheless, the trade investments are aimed at supporting product innovation, which should help Clorox counter stiff competition. In fact, management expects these investments to fuel sales and volumes in the fourth quarter, where EBIT is also expected to rise. All said, Clorox is on track for another strong year, despite slowing economies and a tough consumer landscape.”
  • 6/30/2017 – Clorox Company (The) had its “hold” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $115.00 price target on the stock.

Shares of Clorox Company (CLX) opened at 133.94 on Friday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company’s 50-day moving average price is $133.72 and its 200-day moving average price is $133.47. The company has a market capitalization of $17.29 billion, a PE ratio of 25.11 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same period in the previous year, the firm earned $1.30 earnings per share. The company’s revenue was up 2.9% compared to the same quarter last year. On average, equities analysts expect that Clorox Company will post $5.68 earnings per share for the current fiscal year.

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.